Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
Nuvalent (Nasdaq: NUVL) said CEO James Porter, Ph.D., and CFO Alexandra Balcom will take part in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4, 2025 at 8:30 a.m. ET. A live webcast will be available in the Investors section of the company's website and will be archived for 30 days after the presentation.
Positive
- None.
Negative
- None.
A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentation.
About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626096.html
SOURCE Nuvalent, Inc.
FAQ
When is Nuvalent (NUVL) presenting at the Piper Sandler 2025 conference?
Who will represent Nuvalent (NUVL) at the Piper Sandler 37th Annual Healthcare Conference?
How can investors watch the Nuvalent (NUVL) Piper Sandler presentation?
Where will the Nuvalent (NUVL) webcast be archived and for how long?
Will Nuvalent (NUVL) discuss clinical progress during the Piper Sandler 2025 fireside chat?
